These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21979317)

  • 1. [Treat-to-target (T2T) from the perspective of inpatient rheumatology].
    Lakomek HJ; Krause A
    Z Rheumatol; 2011 Oct; 70(8):656-63. PubMed ID: 21979317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treat-to-target from the perspective of office-based rheumatology].
    Krüger K; Karberg K
    Z Rheumatol; 2011 Oct; 70(8):664-9. PubMed ID: 21979318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quality in acute inpatient rheumatology 2021 : Current aspects of the KOBRA quality label of the Association of Rheumatological Acute Care Clinics].
    Lakomek HJ; Rudwaleit M; Hentschel A; Broge B; Abrolat J; Bessler F; Hellmich B; Klemann A; Krause A; Klass M; Strunk J; Fiori W; Roeder N; Braun J
    Z Rheumatol; 2021 Oct; 80(8):758-770. PubMed ID: 33999267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treat-to-target in rheumatoid arthritis: Evaluating the patient perspective using the Patient Opinion Real-Time Anonymous Liaison system: The RA T2T PORTAL study.
    Benham H; Rutherford M; Kirby S; Stebbings S; White D; Sim D; Harrison A
    Int J Rheum Dis; 2019 May; 22(5):874-879. PubMed ID: 30793870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM).
    Ramiro S; Landewé RB; van der Heijde D; Sepriano A; FitzGerald O; Ostergaard M; Homik J; Elkayam O; Thorne JC; Larche M; Ferraccioli G; Backhaus M; Boire G; Combe B; Schaeverbeke T; Saraux A; Dougados M; Rossini M; Govoni M; Sinigaglia L; Cantagrel AG; Allaart CF; Barnabe C; Bingham CO; Tak PP; van Schaardenburg D; Hammer HB; Dadashova R; Hutchings E; Paschke J; Maksymowych WP
    Ann Rheum Dis; 2020 Apr; 79(4):453-459. PubMed ID: 32094157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [University contribution to implementation of the treat-to-target concept in rheumatology].
    Kalden JR; Müller-Ladner U; Schmidt RE
    Z Rheumatol; 2011 Oct; 70(8):651-5. PubMed ID: 21979316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amendment of the structural quality for inpatient rheumatology. A forward-looking concept].
    Lakomek HJ; Braun J; Gromnica-Ihle E; Fiehn C; Claus S; Specker C; Jung J; Krause A; Lorenz HM; Robbers J
    Z Rheumatol; 2011 Sep; 70(7):615-9. PubMed ID: 21858486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Standards of care for people with rheumatoid arthritis in Europe : Translation and comments of the eumusc.net recommendations supported by EULAR performed by a national task force of the professional organisations DGRh and VRA supported by "Deutsche Rheumaliga"].
    Braun J; Krause A; Aringer M; Burmester G; Bessler F; Engel JM; Faubel U; Fischer-Betz R; Genth E; Gromnica-Ihle E; Hellmich B; Kötter I; Krüger K; Lakomek J; Lorenz HM; Manger B; Märker-Hermann E; Minden K; Müller-Ladner U; Rautenstrauch J; Rehart S; Riemekasten G; Rudwaleit M; Rüther W; Schett G; Schuch F; Schulze-Koops H; Specker C; Wassenberg S; Wiek D; Zink A; Schneider M
    Z Rheumatol; 2016 May; 75(4):416-28. PubMed ID: 27138788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of treat-to-target strategy studies in rheumatic diseases: A systematic review and meta-analysis.
    Hao Y; Oon S; Nikpour M
    Semin Arthritis Rheum; 2024 Aug; 67():152465. PubMed ID: 38796922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The "outcome benchmarking in rheumatologic acute care" project of the Association of Rheumatologic Acute Care Clinics (VRA e.V.) in Germany].
    Roeder N; Lakomek HJ
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(5):343-9. PubMed ID: 21767791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating rheumatoid arthritis to target: an Italian rheumatologists' survey on the acceptance of the treat-to-target recommendations.
    Caporali R; Conti F; Covelli M; Govoni M; Salaffi F; Ventriglia G; Montecucco C
    Clin Exp Rheumatol; 2014; 32(4):471-6. PubMed ID: 24960620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treat-to-target in rheumatology].
    Majdan M
    Wiad Lek; 2015; 68(3):259-64. PubMed ID: 26753210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort.
    Vermeer M; Kuper HH; Bernelot Moens HJ; Hoekstra M; Posthumus MD; van Riel PL; van de Laar MA
    Arthritis Res Ther; 2012 Nov; 14(6):R254. PubMed ID: 23176083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis.
    Tanaka Y; Smolen JS; Jones H; Szumski A; Marshall L; Emery P
    Arthritis Res Ther; 2019 Jul; 21(1):164. PubMed ID: 31277720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating rheumatoid arthritis to target: recommendations assessment questionnaire in Korea.
    Park YB; Koh EM; Kim HY; Park SH; Park W; Bae SC; Song YW; Yoo DH; Yoo B; Lee SK
    Clin Rheumatol; 2013 Dec; 32(12):1791-7. PubMed ID: 24030629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment strategies are more important than drugs in the management of rheumatoid arthritis.
    Drosos AA; Pelechas E; Voulgari PV
    Clin Rheumatol; 2020 Apr; 39(4):1363-1368. PubMed ID: 32088801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of rheumatoid arthritis in clinical practice using treat-to-target strategy: Where do we stand in the multi-ethnic Malaysia population?
    Tan BE; Lim AL; Kan SL; Lim CH; Ng YF; Tng SLC; Hassin NS; Chandran L; Hamid NA; Lee YYL
    Rheumatol Int; 2017 Jun; 37(6):905-913. PubMed ID: 28389855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained beneficial effects of a protocolized treat-to-target strategy in very early rheumatoid arthritis: three-year results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort.
    Vermeer M; Kuper HH; Moens HJ; Drossaers-Bakker KW; van der Bijl AE; van Riel PL; van de Laar MA
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1219-26. PubMed ID: 23436821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM Cohort.
    Sepriano A; Ramiro S; FitzGerald O; Østergaard M; Homik J; van der Heijde D; Elkayam O; Thorne JC; Larché MJ; Ferraccioli G; Backhaus M; Burmester GR; Boire G; Combe B; Schaeverbeke T; Saraux A; Dougados M; Rossini M; Govoni M; Sinigaglia L; Cantagrel A; Barnabe C; Bingham CO; Tak PP; van Schaardenburg D; Hammer HB; Paschke J; Dadashova R; Hutchings E; Landewé R; Maksymowych WP
    J Rheumatol; 2020 Jun; 47(6):809-819. PubMed ID: 31523049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inpatient rheumatology treatment in Germany].
    Kekow J
    Z Rheumatol; 2014 Mar; 73(2):135-8. PubMed ID: 24659149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.